ResearcherHuazhong University of Science and TechnologyActive in the last 2 years

Meng Guan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-4252-6532; OpenAlex author ID A5024692999, A5153539783. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2026.103082 ↗
CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models First author DOI 10.1038/s41467-026-76823-7 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bin Zhang · 1 shared paper, 2026 · strength 0.30
- Paper CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models DOI 10.1038/s41467-026-76823-7 ↗
Jin-Xuan Fan · 1 shared paper, 2026 · strength 0.30
- Paper Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer. DOI 10.1016/j.xcrm.2026.103082 ↗
Qiuran Xu · 1 shared paper, 2026 · strength 0.30
- Paper CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models DOI 10.1038/s41467-026-76823-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.